From Name:
From Email:
To Name:
To Email:

Optional Message:

FDA approves 1st drug to show survival benefit in liposarcoma

from FDA

The U.S. Food and Drug Administration recently approved Halaven, a type of chemotherapy, for the treatment of liposarcoma that cannot be removed by surgery or is advanced. This treatment is approved for patients who received prior chemotherapy that contained an anthracycline drug. more

Powered by MultiBriefs
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063